Treatment Pattern of NOACs (Non-vitamin K Oral Anticoagulants) in Outpatient Users in Colombian Databases (TREND)

Bayer

Status: Completed

Conditions: Atrial Fibrillation

Treatments: Other: Data Collection

Study type: Observational

Funder types: Industry

Identifiers

NCT03474757

20104

Details and patient eligibility

About

This population-based descriptive study will characterize first-time users of three NOACs (rivaroxaban, dabigatran and apixaban) in prevention of stroke in non-valvular atrial fibrillation (SPAF) patients and will assess the patterns of drug utilization in routine general practice in Colombia

Enrollment: 10,528 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• First prescription of NOACs (rivaroxaban, dabigatran and apixaban) in the outpatient setting.
• Non valvular Atrial Fibrillation (NVAF) Patients
• aged ≥18 years
• at least one year of enrollment in the Audifarma database
• one year since first encounter with healthcare provider will be included in the study

Exclusion criteria

• Patients with any record of index drug prescription prior to the enrolment period.
• Patients who qualify as members of more than one cohort study on the same day

Trial design

10,528 participants in 3 patient groups

SPAF patients in Colombia_Rivaroxaban

Description:

First time users of rivaroxaban in the Audifarma database

Treatment:

Other: Data Collection

SPAF patients in Colombia_Dabigatran

Description:

First time users of dabigatran in the Audifarma database

Treatment:

Other: Data Collection

SPAF patients in Colombia_Apixaban

Description:

First time users of apixaban in the Audifarma database

Treatment:

Other: Data Collection